ELIZABETH VERNO: Open Payments
NPI 1740851732 · WATERTOWN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,089 in 36 payments from 12 companies in 2025. Trend: 2023 $93 · 2024 $273 · 2025 $1,089
Food & beverage: $1,089
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 15 | $437 |
| Madrigal Pharmaceuticals | 3 | $232 |
| Amgen Inc. | 3 | $80 |
| Ascendis Pharma Endocrinology Inc | 3 | $73 |
| Lilly USA, LLC | 2 | $55 |
| Sequel Med Tech, LLC | 2 | $43 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $41 |
| Insulet Corporation | 1 | $31 |
| Tandem Diabetes Care, Inc. | 2 | $29 |
| Dexcom, Inc. | 1 | $24 |
Products named: Ozempic, REZDIFFRA, Yorvipath, TEPEZZA, MOUNJARO, TWIIST, Kerendia, Omnipod.
Industry payments across NY — which companies pay providers there.
